Achilles Therapeutics plc
ACHL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $132 | $173 | $266 | $178 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $10 | $16 | $11 | $7 |
| Inventory | $0 | $5 | $5 | $0 |
| Other Curr. Assets | $4 | $3 | $2 | $3 |
| Total Curr. Assets | $146 | $197 | $285 | $188 |
| Property Plant & Equip (Net) | $14 | $20 | $29 | $28 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $3 | $4 | $3 |
| Total NC Assets | $16 | $24 | $32 | $31 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $161 | $220 | $317 | $219 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $4 | $6 |
| Short-Term Debt | $4 | $4 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $10 | $5 |
| Other Curr. Liab. | $8 | $8 | $11 | $7 |
| Total Curr. Liab. | $17 | $18 | $19 | $17 |
| LT Debt | $1 | $4 | $8 | $12 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $2 | $5 | $8 | $13 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $9 | $12 | $16 |
| Total Liabilities | $19 | $23 | $28 | $30 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$260 | -$190 | -$119 | -$58 |
| AOCI | -$13 | -$22 | $7 | $12 |
| Other Equity | $415 | $409 | $402 | $235 |
| Total Equity | $142 | $197 | $290 | $189 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $161 | $220 | $317 | $219 |
| Net Debt | -$127 | -$165 | -$254 | -$162 |